The relationship of sleep duration and insomnia to risk of hypertension incidence: A meta-analysis of prospective cohort studies

Hypertension Research

Volumn 36, Issue 11, 2013, Pages 985-995

  Meng, Lin ^a   Zheng, Yang ^a   Hui, Rutai ^b  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b FUWAI HOSPITAL   (China)

Author keywords

insomnia; meta analysis; sleep; sleep disorder

Indexed keywords

AROUSAL; ARTICLE; FOLLOW UP; HUMAN; HYPERTENSION; INSOMNIA; POLYSOMNOGRAPHY; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RISK FACTOR; SLEEP TIME;

HUMANS; HYPERTENSION; INCIDENCE; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 84887140036     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.70     Document Type: Article

References (51)

1. Stenberg D. Neuroanatomy and neurochemistry of sleep. Cell Mol Life Sci 2007; 64: 1187-1204.
2. Rechtschaffen A, Bergmann BM, Everson CA, Kushida CA, Gilliland MA. Sleep deprivation in the rat: X. Integration and discussion of the findings. Sleep 1989; 12: 68-87.
3. Mitchell HA, Weinshenker D. Good night and good luck: norepinephrine in sleep pharmacology. Biochem Pharmacol 2010; 79: 801-809.
4. Tasali E, Leproult R, Spiegel K. Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Prog Cardiovasc Dis 2009; 51: 381-391.
5. Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C. The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 2010; 14: 19-31.
6. Ebben MR, Spielman AJ. Non-pharmacological treatments for insomnia. J Behav Med 2009; 32: 244-254.
7. Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab 2010; 24: 731-743.
8. Grandner MA, Patel NP, Gehrman PR, Perlis ML, Pack AI. Problems associated with short sleep: bridging the gap between laboratory and epidemiological studies. Sleep Med Rev 2010; 14: 239-247.
9. Akerstedt T, Nilsson PM. Sleep as restitution: an introduction. J Intern Med 2003; 254: 6-12.
10. Gangwisch JE, Malaspina D, Boden-Albala B, Heymsfield SB. Inadequate sleep as a risk factor for obesity: analyses of the nhanes i. Sleep 2005; 28: 1289-1296.
11. Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, Rundle AG, Zammit GK, Malaspina D. Short sleep duration as a risk factor for hypertension: analyses of the first national health and nutrition examination survey. Hypertension 2006; 47: 833-839.
12. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002; 59: 131-136.
13. Sutton DA, Moldofsky H, Badley EM. Insomnia and health problems in Canadians. Sleep 2001; 24: 665-670.
14. Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2010; 33: 414-420.
15. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27: 1318-1324.
16. Lusardi P, Zoppi A, Preti P, Pesce RM, Piazza E, Fogari R. Effects of insufficient sleep on blood pressure in hypertensive patients: a 24-h study. Am J Hypertens 1999; 12: 63-68.
17. Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43: 192-197.
18. Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, Lauderdale DS. Association between sleep and blood pressure in midlife: the cardia sleep study. Arch Intern Med 2009; 169: 1055-1061.
19. Gottlieb DJ, Redline S, Nieto FJ, Baldwin CM, Newman AB, Resnick HE, Punjabi NM. Association of usual sleep duration with hypertension: the sleep heart health study. Sleep 2006; 29: 1009-1014.
20. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 2009; 32: 491-497.
21. Friedman O, Shukla Y, Logan AG. Relationship between self-reported sleep duration and changes in circadian blood pressure. Am J Hypertens 2009; 22: 1205-1211.
22. Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J Clin Sleep Med 2007; 3: 489-494.
23. Phillips B, Buzkova P, Enright P. Insomnia did not predict incident hypertension in older adults in the cardiovascular health study. Sleep 2009; 32: 65-72.
24. Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, Bixler EO. Insomnia with objective short sleep duration and incident hypertension: the penn state cohort. Hypertension 2012; 60: 929-935.
25. Suka M, Yoshida K, Sugimori H. Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 2003; 45: 344-350.
26. Gangwisch JE, Malaspina D, Posner K, Babiss LA, Heymsfield SB, Turner JB, Zammit GK, Pickering TG. Insomnia and sleep duration as mediators of the relationship between depression and hypertension incidence. Am J Hypertens 2010; 23: 62-69.
27. Wang Q, Xi B, Liu M, Zhang Y, Fu M. Short sleep duration is associated with hypertension risk among adults: A systematic review and meta-analysis. Hypertens Res 2012; 35: 1012-1018.
28. Kim SJ, Lee SK, Kim SH, Yun CH, Kim JH, Thomas RJ, Shin C. Genetic association of short sleep duration with hypertension incidence-a 6-year follow-up in the Korean genome and epidemiology study. Circ J 2012; 76: 907-913.
29. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The prisma statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151: W65-W94.
30. Cappuccio FP, Stranges S, Kandala NB, Miller MA, Taggart FM, Kumari M, Ferrie JE, Shipley MJ, Brunner EJ, Marmot MG. Gender-specific associations of short sleep duration with prevalent and incident hypertension: The whitehall ii study. Hypertension 2007; 50: 693-700.
31. Lopez-Garcia E, Faubel R, Guallar-Castillon P, Leon-Munoz L, Banegas JR, Rodriguez-Artalejo F. Self-reported sleep duration and hypertension in older spanish adults. J Am Geriatr Soc 2009; 57: 663-668.
32. Beunza JJ, Martinez-Gonzalez MA, Ebrahim S, Bes-Rastrollo M, Nunez J, Martinez JA, Alonso A. Sedentary behaviors and the risk of incident hypertension: the sun cohort. Am J Hypertens 2007; 20: 1156-1162.
33. Rod NH, Vahtera J, Westerlund H, Kivimaki M, Zins M, Goldberg M, Lange T. Sleep disturbances and cause-specific mortality: results from the gazel cohort study. Am J Epidemiol 2011; 173: 300-309.
34. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (nos) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical- epidemiology/oxford. htm. (accessed 7 September, 2010). 2008.
35. Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med 2002; 21: 1559-1573.
36. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on meta-analyses. BMJ 2000; 320: 1574-1577.
37. He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367: 320-326.
38. Lauderdale DS, Knutson KL, Yan LL, Liu K, Rathouz PJ. Self-reported and measured sleep duration: how similar are they? Epidemiology 2008; 19: 838-845.
39. Hauri PJ, Wisbey J. Wrist actigraphy in insomnia. Sleep 1992; 15: 293-301.
40. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. J Sleep Res 1999; 8: 175-183.
41. Kario K, Schwartz JE, Pickering TG. Changes of nocturnal blood pressure dipping status in hypertensives by nighttime dosing of alpha-adrenergic blocker, doxazosin: results from the halt study. Hypertension 2000; 35: 787-794.
42. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G, Fogari R. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens 1996; 9: 503-505.
43. Miller MA, Cappuccio FP. Inflammation, sleep, obesity and cardiovascular disease. Curr Vasc Pharmacol 2007; 5: 93-102.
44. Wolk R, Somers VK. Sleep and the metabolic syndrome. Exp Physiol 2007; 92: 67-78.
45. Goncharuk VD, van Heerikhuize J, Dai JP, Swaab DF, Buijs RM. Neuropeptide changes in the suprachiasmatic nucleus in primary hypertension indicate functional impairment of the biological clock. J Comp Neurol 2001; 431: 320-330.
46. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435-1439.
47. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141: 846-850.
48. Gallicchio L, Kalesan B. Sleep duration and mortality: a systematic review and meta-analysis. J Sleep Res 2009; 18: 148-158.
49. Grandner MA, Drummond SP. Who are the long sleepers? Towards an understanding of the mortality relationship. Sleep Med Rev 2007; 11: 341-360.
50. Bonnet MH, Arand DL. Hyperarousal and insomnia: state of the science. Sleep Med Rev 2010; 14: 9-15.
51. Bonnet MH. Evidence for the pathophysiology of insomnia. Sleep 2009; 32: 441-442.